On the heels of the U.S. Patent and Trademark Office Acting Director’s recent decision to deny institution of iRhythm Technologies’ inter partes review petition, the PTO has now issued additional decisions clarifying the role of parties’ “expectations” in IPR proceedings. Along with the Acting Director’s guidance regarding discretionary denials of institution, decisions on two recent petitions further illuminate the PTO’s view of which factors should be given weight in deciding whether to deny an IPR petition.

As we previously discussed, in denying institution of iRhythm’s IPR petition, the Acting Director explained that iRhythm’s disclosure of the challenged patent 12 years prior in an information disclosure statement (IDS) indicated it had long been aware of the patent and failed to seek early review. The Acting Director concluded that this factor weighed heavily in favor of denial—even more so than traditionally Fintiv-style factors, such as time-to-trial, investment in the parallel proceeding, and merits of the petition. This factor—including whether a patentee should expect to defend an IPR petition or whether a challenger should expect to be sued—marks a notable expansion of the factors considered in the PTO’s discretionary denial analysis.

In Dabico Airport Solutions Inc., the PTO denied Dabico’s IPR petition because “the challenged patent had been in force almost eight years, creating settled expectations.” The decision did not shed light on how long a patent must be in force to give rise to a settled expectation that there will not be a PTO challenge, but did explain that “the longer the patent has been in force, the more settled expectations should be.” Indeed, the decision went further to note that patents are publicly available so actual notice is not required to create a patentee’s settled expectation that it will not face a challenge.

One week later, the PTO denied several other petitions, including Intel’s IPR petition in Intel Corp. v. Proxense LLC. Citing the Dabico decision, the PTO noted that the challenged patents were in force for over nine years which “create[ed] settled expectations” for the patentee. In the decision, however, the PTO recognized two situations where a late challenge may be considered appropriate, including: (1) a significant change in law; or (2) the patent may not have been commercialized, marked, asserted, or licensed within the petitioner’s technology space.

In the evolving landscape of discretionary denials, these decisions add a new dimension to the IPR strategy playbook. Patent challengers should certainly consider filing IPR petitions early—prior to an assertion of infringement—once aware of a patent within the challenger’s technological space. Of course, this approach does not come without risk as IPR petitions may be costly and may trigger an infringement action from the patentee. On the other hand, patentees can create settled expectations once their patents have been in force for years and safely assert them against potential infringers with a certain level of confidence that any IPR petitions are likely to be denied if the challenger failed to previously challenge the known patent. These decisions strengthen the ability to assert older patents with greater confidence, particularly if potential challengers were or should have been aware of the patent and declined to act earlier.

We are continuing to monitor the USPTO’s evolving guidance on discretionary denials and decisions. We are happy to discuss any questions you may have regarding how these developments may affect your IPR strategy.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Erik Milch Erik Milch

Erik Milch is a partner in the Litigation Department and a member of the Intellectual Property, Patent Law and Trials group.

Erik brings more than 20 years of experience litigating in key jurisdictions across the U.S., as well as before the International Trade…

Erik Milch is a partner in the Litigation Department and a member of the Intellectual Property, Patent Law and Trials group.

Erik brings more than 20 years of experience litigating in key jurisdictions across the U.S., as well as before the International Trade Commission and the U.S. Patent and Trademark Office. As a first-chair trial lawyer, Erik litigates complex matters involving medical devices, life sciences instrumentation, pharmaceuticals, electrical and computer technology, and consumer products. He regularly counsels clients in a range of industries in connection with patent procurement, development of patent portfolios, patent licensing, valuation of patent portfolios in business transactions and transactional diligence.

Erik has extensive experience in all aspects of patent litigation from pre-filing through appeal, including enforcement of patents against competitors and defense of patent infringement allegations. His technical background includes microfluidics, lab automation, optical imaging instruments, wound closure, surgical instrumentation, orthopedics, autoinjectors, tissue resection and sealing, pharmaceuticals, haptic feedback systems, computer software, consumer products, fluid mechanics applications, automotive engines and mechanical and electrical components, aerospace propulsion and control systems, weapons systems, and telecommunications.

Erik has been consistently recognized in Chambers USA and IAM Patent 1000 for his significant expertise in patent litigation. He was also recognized as a “Top Lawyer” by The Washingtonian.

Prior to pursuing a legal career, Erik earned a bachelor’s degree in mechanical engineering from Georgia Tech, where he developed a deep appreciation for cutting-edge technology and its potential to drive progress. His background in engineering equips him with a unique ability to comprehend intricate technical concepts. This enables him to effectively navigate the intricate world of patent litigation, combining his legal skills with technical know-how to provide comprehensive and strategic counsel to his clients.

In addition to his academic accomplishments, Erik served as an officer in the United States Navy. His military background instilled in him a strong sense of discipline, leadership, perseverance, and attention to detail; qualities that continue to guide him in his legal practice.

Photo of Elizabeth Shrieves Elizabeth Shrieves

Elizabeth (Beth) Shrieves is an associate in the Litigation Department and a member of the Intellectual Property and Patent Law groups. Beth has experience litigating in numerous federal district courts across the United States, as well as before the Federal Circuit, U.S. Patent…

Elizabeth (Beth) Shrieves is an associate in the Litigation Department and a member of the Intellectual Property and Patent Law groups. Beth has experience litigating in numerous federal district courts across the United States, as well as before the Federal Circuit, U.S. Patent and Trademark Office, and International Trade Commission. Beth’s experience covers a wide variety of products and technology involving software and applications, medical devices and technology, electrical hardware, telecommunications, supercapacitors, automotive engines, weapon systems, and consumer products. She has counseled clients throughout all stages of litigation, including both plaintiff and defense work, from pre-suit investigation, initial pleadings, discovery, trial, and through appeal.

Beth graduated from George Mason University School of Law where she earned her J.D., Magna Cum Laude. Prior to earning her law degree, she received a bachelor’s degree from Wake Forest University where she also graduated Magna Cum Laude. Beth also previously worked as a paralegal where she gained a deeper understanding of the nuances of commercial litigation.